These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. The podocyte: a major player in the development of diabetic nephropathy? Marshall SM Horm Metab Res; 2005 Apr; 37 Suppl 1():9-16. PubMed ID: 15918105 [TBL] [Abstract][Full Text] [Related]
46. Why is proteinuria such an important risk factor for progression in clinical trials? Jerums G; Panagiotopoulos S; Tsalamandris C; Allen TJ; Gilbert RE; Comper WD Kidney Int Suppl; 1997 Dec; 63():S87-92. PubMed ID: 9407431 [TBL] [Abstract][Full Text] [Related]
47. The renal endothelium in diabetic nephropathy. Eleftheriadis T; Antoniadi G; Pissas G; Liakopoulos V; Stefanidis I Ren Fail; 2013; 35(4):592-9. PubMed ID: 23472883 [TBL] [Abstract][Full Text] [Related]
48. Proteinuria in diabetic patients--is it always diabetic nephropathy? Bergner R; Lenz T; Henrich DM; Hoffmann M; Uppenkamp M Kidney Blood Press Res; 2006; 29(1):48-53. PubMed ID: 16636578 [TBL] [Abstract][Full Text] [Related]
49. The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy? Reddy GR; Kotlyarevska K; Ransom RF; Menon RK Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):32-6. PubMed ID: 18090667 [TBL] [Abstract][Full Text] [Related]
50. An open label, randomized controlled study of oral calcitriol for the treatment of proteinuria in patients with diabetic kidney disease. Krairittichai U; Mahannopkul R; Bunnag S J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S41-7. PubMed ID: 22619886 [TBL] [Abstract][Full Text] [Related]
51. Allograft diabetic nephropathy may progress to end-stage renal disease. Salifu MO; Nicastri AD; Markell MS; Ghali H; Sommer BG; Friedman EA Pediatr Transplant; 2004 Aug; 8(4):351-6. PubMed ID: 15265161 [TBL] [Abstract][Full Text] [Related]
52. The patterns of proteinuria in diabetes mellitus. Relevance to pathogenesis and prevention of diabetic nephropathy. Viberti G; Keen H Diabetes; 1984 Jul; 33(7):686-92. PubMed ID: 6376224 [No Abstract] [Full Text] [Related]
53. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy. Al-Douahji M; Brugarolas J; Brown PA; Stehman-Breen CO; Alpers CE; Shankland SJ Kidney Int; 1999 Nov; 56(5):1691-9. PubMed ID: 10571777 [TBL] [Abstract][Full Text] [Related]
54. Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure. Tryggvason K; Pettersson E J Intern Med; 2003 Sep; 254(3):216-24. PubMed ID: 12930230 [TBL] [Abstract][Full Text] [Related]
55. Clinico-pathological features of kidney disease in diabetic cases. Furuichi K; Shimizu M; Okada H; Narita I; Wada T Clin Exp Nephrol; 2018 Oct; 22(5):1046-1051. PubMed ID: 29564666 [TBL] [Abstract][Full Text] [Related]
56. Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease. Petrazzuolo A; Sabiu G; Assi E; Maestroni A; Pastore I; Lunati ME; Montefusco L; Loretelli C; Rossi G; Ben Nasr M; Usuelli V; Xie Y; Balasubramanian HB; Zocchi M; El Essawy B; Yang J; D'Addio F; Fiorina P Pharmacol Res; 2023 Apr; 190():106710. PubMed ID: 36871895 [TBL] [Abstract][Full Text] [Related]
57. Histological Examination of the Diabetic Kidney. Carrara C; Abbate M; Conti S; Rottoli D; Rizzo P; Marchetti G Methods Mol Biol; 2020; 2067():63-87. PubMed ID: 31701446 [TBL] [Abstract][Full Text] [Related]
58. Proteinuria and progression in human glomerular diseases. Cameron JS Am J Nephrol; 1990; 10 Suppl 1():81-7. PubMed ID: 2256480 [TBL] [Abstract][Full Text] [Related]
59. Recent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis. Hung PH; Hsu YC; Chen TH; Lin CL Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769288 [TBL] [Abstract][Full Text] [Related]
60. Diabetic proteinuria. Glomerular or tubular in origin? Abrass CK Am J Nephrol; 1984; 4(6):337-46. PubMed ID: 6393768 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]